VVOS vs. INBS, OSA, AVGR, NURO, PSTV, VAPO, BTCY, TMDIF, VERO, and TNON
Should you be buying Vivos Therapeutics stock or one of its competitors? The main competitors of Vivos Therapeutics include Intelligent Bio Solutions (INBS), ProSomnus (OSA), Avinger (AVGR), NeuroMetrix (NURO), Plus Therapeutics (PSTV), Vapotherm (VAPO), Biotricity (BTCY), Titan Medical (TMDIF), Venus Concept (VERO), and Tenon Medical (TNON). These companies are all part of the "surgical & medical instruments" industry.
Intelligent Bio Solutions (NASDAQ:INBS) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment.
Vivos Therapeutics has a net margin of -117.06% compared to Vivos Therapeutics' net margin of -354.86%. Vivos Therapeutics' return on equity of -210.36% beat Intelligent Bio Solutions' return on equity.
33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are held by institutional investors. 0.3% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 9.6% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Intelligent Bio Solutions has a beta of 4.87, suggesting that its stock price is 387% more volatile than the S&P 500. Comparatively, Vivos Therapeutics has a beta of 8.03, suggesting that its stock price is 703% more volatile than the S&P 500.
In the previous week, Vivos Therapeutics had 5 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 7 mentions for Vivos Therapeutics and 2 mentions for Intelligent Bio Solutions. Vivos Therapeutics' average media sentiment score of 0.44 beat Intelligent Bio Solutions' score of 0.31 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.
Intelligent Bio Solutions has higher earnings, but lower revenue than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
Vivos Therapeutics received 12 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users.
Summary
Intelligent Bio Solutions and Vivos Therapeutics tied by winning 7 of the 14 factors compared between the two stocks.
Get Vivos Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VVOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivos Therapeutics Competitors List
Related Companies and Tools
